dexchlorpheniramine (CED0010643)

Record Information
Version1.0
Creation Date2016-06-03 10:52:07 UTC
Update Date2026-05-14 19:35:57 UTC
Accession NumberCHEM043386
Identification
Common Namedexchlorpheniramine
ClassSmall Molecule
Description
Dexchlorpheniramine is an organic compound with the formula C16H19ClN2 and an average molecular weight of 274.79 g/mol. It is found in or released from healthcare, pharmaceuticals, and veterinary products as an antihistamine, with oral recorded exposure routes. In terms of protein targets, it acts as an antagonist of the Histamine H1 receptor (HRH1). Dexchlorpheniramine belongs to the pheniramines, a subclass of pyridines and derivatives within the organic compounds.
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropaneChEBI
1-(p-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamineChEBI
2-[p-Chloro-alpha-[2-(dimethylamino)ethyl]benzyl]pyridineChEBI
3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamineChEBI
ChlorophenylpyridamineChEBI
ChlorphenaminChEBI
ChlorphenaminumChEBI
ChlorpheniraminumChEBI
ClofeniraminaChEBI
ClorfenaminaChEBI
ClorfeniraminaChEBI
gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamineChEBI
gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamineChEBI
HaynonChEBI
ChlorphenamineKegg
2-[p-Chloro-a-[2-(dimethylamino)ethyl]benzyl]pyridineGenerator
2-[p-Chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridineGenerator
g-(4-Chlorophenyl)-g-(2-pyridyl)propyldimethylamineGenerator
Γ-(4-chlorophenyl)-γ-(2-pyridyl)propyldimethylamineGenerator
g-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamineGenerator
Γ-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamineGenerator
Chlor-trimetonHMDB
Chloropheniramine maleateHMDB
Chlorphenamine hydrogen maleateHMDB
Chlorphenamine maleateHMDB
Chlorpheniaramine maleateHMDB
Chlorpheniramine maleateHMDB
TeldrinHMDB
Aller-chlorHMDB
Chlor-tripolonHMDB
ChlorproHMDB
Cloro-trimetonHMDB
KlorominHMDB
Maleate, chlorpheniramineHMDB
PiritonHMDB
Rugby brand OF chlorpheniramine maleateHMDB
Schering-plough brand OF chlorpheniramine maleateHMDB
Tannate, chlorpheniramineHMDB
Bayer brand OF chlorpheniramine maleateHMDB
Chlo-amineHMDB
Hogil brand 1 OF chlorpheniramine maleateHMDB
Llorens brand OF chlorpheniramine maleateHMDB
Schering brand OF chlorpheniramine maleateHMDB
Vortech brand 1 OF chlorpheniramine maleateHMDB
Antihistaminico llorensHMDB
ChlorprophenpyridamineHMDB
Chlorspan 12HMDB
Chlortab-4HMDB
Halsey drug brand OF chlorpheniramine maleateHMDB
Stafford-miller brand OF chlorpheniramine maleateHMDB
Vortech brand 3 OF chlorpheniramine maleateHMDB
Chlor-100HMDB
Chlorpheniramine tannateHMDB
Efidac 24HMDB
Hogil brand 2 OF chlorpheniramine maleateHMDB
Intra brand OF chlorpheniramine maleateHMDB
Schein brand OF chlorpheniramine maleateHMDB
Vortech brand 2 OF chlorpheniramine maleateHMDB
Chemical FormulaC16H19ClN2
Average Molecular Mass274.788 g/mol
Monoisotopic Mass274.124 g/mol
CAS Registry Number25523-97-1
IUPAC Name[3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine
Traditional Namechlorpheniramine
SMILESCN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
InChI IdentifierInChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3
InChI KeySOYKEARSMXGVTM-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as pheniramines. Pheniramines are compounds containing a pheniramine moiety, which is structurally characterized by the presence of a 2-benzylpyridine linked to an dimethyl(propyl)amine to form a dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine skeleton.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassPyridines and derivatives
Sub ClassPheniramines
Direct ParentPheniramines
Alternative Parents
Substituents
  • Pheniramine
  • Chlorobenzene
  • Halobenzene
  • Aralkylamine
  • Aryl chloride
  • Benzenoid
  • Monocyclic benzene moiety
  • Aryl halide
  • Heteroaromatic compound
  • Tertiary aliphatic amine
  • Tertiary amine
  • Azacycle
  • Organic nitrogen compound
  • Organonitrogen compound
  • Organochloride
  • Organohalogen compound
  • Amine
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.052 g/LALOGPS
logP3.74ALOGPS
logP3.58ChemAxon
logS-3.7ALOGPS
pKa (Strongest Basic)9.47ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area16.13 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity80.85 m³·mol⁻¹ChemAxon
Polarizability30.82 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
GC-MSGC-MS Spectrumsplash10-0zfr-6290000000-2ca3230cde716588805eNot AvailableView Spectrum
GC-MSGC-MS Spectrumsplash10-0zfr-6290000000-2ca3230cde716588805eNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0a4i-9380000000-f4a0f7b13adeafb1762dNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-01b9-3900000000-ea4ccfd2afe05f49fc7aNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-004i-0090000000-9e46eb080de95d4f8f8eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-1920000000-d2d2acf559d9070a1d47Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0zfr-6190000000-2ca3230cde716588805eNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0uy0-0960000000-1f750af75fe542c6c06fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0290000000-03651b7b90a1745fdf23Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-0uy0-0960000000-1f750af75fe542c6c06fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-001i-0490000000-3d28aeb0e77391e8e9b2Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-0090000000-9b4d486e9c2c7712ca4dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0059-0190000000-2c96b165338a445b284dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0ue9-3960000000-73025748bd5a00459938Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-0090000000-90a6e640c735788d17caNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-1090000000-89ac3cf688134ba8a50bNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-01tc-6490000000-4242ef7cec7b0b0a7393Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-0090000000-c38223f80e776a39c840Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-0090000000-5c9ac02f7374772460c8Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0ue9-1290000000-cc70655f6b19de3dc41dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-0090000000-df52e539d08e1efa7d95Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-4390000000-4b1316bcb291af4998c9Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0ue9-8490000000-4bf6d67eb7d38a21b96bNot AvailableView Spectrum
MSMS Spectrumsplash10-0zfr-6490000000-8e58cd1c686f23a7dac6Not AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
265.0Log mg/kg[150:470]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
393AntihistaminesHealthcare, pharmaceuticals & veterinary productsNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Histamine H1 receptor structureClick to view 3D structureHistamine H1 receptorP35367HumansPredicted (SEA)1.40129
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)14.0129
Click to view 3D structureHistamine H1 receptorP31390Rattus norvegicusPredicted (SEA)0.934191
Muscarinic acetylcholine receptor M1 structureClick to view 3D structureMuscarinic acetylcholine receptor M1P11229HumansPredicted (SEA)7.78492
Muscarinic acetylcholine receptor M3 structureClick to view 3D structureMuscarinic acetylcholine receptor M3P20309HumansPredicted (SEA)5.52729
Muscarinic acetylcholine receptor M5 structureClick to view 3D structureMuscarinic acetylcholine receptor M5P08912HumansPredicted (SEA)3.42537
Muscarinic acetylcholine receptor M2 structureClick to view 3D structureMuscarinic acetylcholine receptor M2P08172HumansPredicted (SEA)5.60514
Muscarinic acetylcholine receptor M4 structureClick to view 3D structureMuscarinic acetylcholine receptor M4P08173HumansPredicted (SEA)5.83869
Click to view 3D structureHistamine H1 receptorP31389Cavia porcellusPredicted (SEA)6.61718
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP28223HumansPredicted (SEA)74.346
Sodium-dependent dopamine transporter structureClick to view 3D structureSodium-dependent dopamine transporterQ01959HumansPredicted (SEA)21.5642
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansPredicted (SEA)15.7255
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)52.2368
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)41.805
Alpha-2A adrenergic receptor structureClick to view 3D structureAlpha-2A adrenergic receptorP08913HumansPredicted (SEA)23.8997
Histamine H2 receptor structureClick to view 3D structureHistamine H2 receptorP25021HumansPredicted (SEA)10.5875
Alpha-2B adrenergic receptor structureClick to view 3D structureAlpha-2B adrenergic receptorP18089HumansPredicted (SEA)17.6718
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)54.4945
Click to view 3D structureAlpha-1B adrenergic receptorP15823Rattus norvegicusPredicted (SEA)13.7015
Click to view 3D structureHistamine H3 receptorQ9JI35Cavia porcellusPredicted (SEA)7.70707
Click to view 3D structureSodium-dependent serotonin transporterP31652Rattus norvegicusPredicted (SEA)59.5547
Click to view 3D structureNorepinephrine transporterQ9WTR4Rattus norvegicusPredicted (SEA)25.3788
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)329.458
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)208.247
Histamine H3 receptor structureClick to view 3D structureHistamine H3 receptorQ9Y5N1HumansPredicted (SEA)74.5017
Concentrations
Not Available
External Links
DrugBank IDDB01114
HMDB IDHMDB0001944
FooDB IDFDB022759
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN ID1734
PDB IDNot Available
Wikipedia LinkChlorpheniramine
Chemspider ID2624
ChEBI ID52010
PubChem Compound ID2725
Kegg Compound IDC06905
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=10796091
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=11284026
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=16119587
4. https://www.ncbi.nlm.nih.gov/pubmed/?term=16413139
5. Bantz EW, Dolen WK, Chadwick EW, Nelson HS: Chronic chlorpheniramine therapy: subsensitivity, drug metabolism, and compliance. Ann Allergy. 1987 Nov;59(5):341-6.
6. Simons FE, Silver NA, Gu X, Simons KJ: Clinical pharmacology of H1-antihistamines in the skin. J Allergy Clin Immunol. 2002 Nov;110(5):777-83.
7. MSDS: http://msds.orica.com/pdf/shess-en-cds-010-000000033835.pdf